Nutritional Assesment in Patients With Cirrhosis

NCT ID: NCT05729438

Last Updated: 2024-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluated nutritional status in patiets with cirrhosis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cirrhosis, Liver

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BCAA

status of nutrition evaluation after 3 months of BCAA

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

branched chain amino acids

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* signed informed consent
* age \>18, \<75 years old
* hepatic cirrhosis diagnosis

Exclusion Criteria

* refuse to participate/to give consent
* presence of musculo-skeletal disease previous diagnosed, neuropathic diseases, malignancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SUUMC Central Military Hospital Dr Carol Davila

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bucurica Sandica

Principal Investigator, Head of Functional Exploring Laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Suumc

Bucharest, București - Sector1, Romania

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Romania

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

SANDICA BUCURICA

Role: CONTACT

Phone: 0213193051

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

SANDICA BUCURICA

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

559

Identifier Type: -

Identifier Source: org_study_id